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Tail-anchored (TA) proteins, defined by the presence
of a single C-terminal transmembrane domain (TMD),
play critical roles throughout the secretory pathway
and in mitochondria, yet the machinery responsible
for their proper membrane insertion remains poorly
characterized. Here we show that Get3, the yeast
homolog of the TA-interacting factor Asna1/Trc40,
specifically recognizes TMDs of TA proteins destined
for the secretory pathway. Get3 recognition repre-
sents a key decision step, whose loss can lead to
misinsertion of TA proteins into mitochondria.
Get3-TA protein complexes are recruited for endo-
plasmic reticulum (ER) membrane insertion by the
Get1/Get2 receptor. In vivo, the absence of Get1/
Get2 leads to cytosolic aggregation of Get3-TA com-
plexes and broad defects in TA protein biogenesis.
In vitro reconstitution demonstrates that the Get pro-
teins directly mediate insertion of newly synthesized
TA proteins into ERmembranes. Thus, the GET com-
plex represents a critical mechanism for ensuring
efficient and accurate targeting of TA proteins.
INTRODUCTION
The biogenesis of transmembrane proteins presents the cell
with several compounding challenges. Prior to membrane inser-
tion, hydrophobic transmembrane domains (TMDs) are prone to
aggregation, and the spontaneous insertion of TMDs across
lipid bilayers, even when thermodynamically favored, can be
slow. Moreover, proteins containing TMDs must find their
correct target membrane for insertion among the different mem-
brane-surrounded compartments present in eukaryotic cells. To
face these challenges, cells have evolved diverse mechanisms
for chaperoning membrane proteins, often from the earliest634 Cell 134, 634–645, August 22, 2008 ª2008 Elsevier Inc.stages of their biosynthesis on the ribosome to their proper des-
tinations. Such pathways have been the subject of intense in-
vestigations and include the signal recognition particle (SRP)/
Sec61 translocon system that imports secretory pathway
proteins into the endoplasmic reticulum (ER) (Egea et al.,
2005; Rapoport et al., 1999; Wickner and Schekman, 2005)
and the transport inner membrane/transport outer membrane
(Tim/Tom) translocases that mediate insertion of transmem-
brane proteins into both mitochondrial membranes (Neupert,
1997; Pfanner and Meijer, 1997).
Far less is known about the machinery responsible for the in-
sertion of an important class of proteins that are anchored to
the lipid bilayer by a single TMD located near their C termini.
This topological arrangement allows tail-anchored (TA) proteins
to be tethered to internal membranes while presenting their func-
tional N-terminal domains to the cytosol (Borgese et al., 2007;
Wattenberg and Lithgow, 2001). TA proteins are found through-
out the secretory pathway, in the nuclear envelope, peroxi-
somes, and mitochondria. Within the secretory pathway, TA
proteins play diverse roles, such as enabling vesicular traffic
(e.g., many of the SNAREs, which mediate fusion of secretory
vesicles, are TA proteins [Beilharz et al., 2003]), aiding in protein
translocation, and promoting folding or degradation of mem-
brane proteins (Borgese et al., 2007; Wattenberg and Lithgow,
2001). Secretory pathway TA proteins are first inserted into the
ER membrane, and are then sorted to their ultimate destination
(Bulbarelli et al., 2002). In contrast, mitochondrial TA proteins
are inserted directly into the mitochondrial membrane, where
they facilitate mitochondrial fission, provide key components of
the translocation machinery, and act in apoptosis (Borgese
et al., 2007; Wattenberg and Lithgow, 2001). The membrane
specificity of TA proteins is largely encoded in their TMDs and
flanking regions (Egan et al., 1999). These signals, however,
are not absolute, as some TA proteins, such as the mammalian
oncoprotein Bcl2 (Krajewski et al., 1993; Lithgow et al., 1994),
are found in both the mitochondria and the ER. Moreover, it is
not well understood how targeting determinants in the TMDs
are decoded by cellular machinery (Borgese et al., 2007).
Because of its position near the C terminus, the TMD of TA
proteins is occluded by the ribosome until translation is com-
pleted. Thus, TA proteins cannot exploit the classic cotransla-
tional SRP/Sec61 translocation mechanism used by most secre-
tory pathway proteins (Yabal et al., 2003). Early studies with cell
extracts indicated that some TA proteins, such as CytB5, could
integrate into membranes without the assistance of specialized
machinery (Brambillasca et al., 2006; Rachubinski et al., 1980).
However, most TA proteins, such as the mammalian Sec61b
and synaptobrevin, have more hydrophobic TMDs, rendering
them reliant on an incompletely characterized, ATP-dependent
mechanism (Abell et al., 2007; High and Abell, 2004; Stefanovic
and Hegde, 2007; Favaloro et al., 2008).
Recently, biochemical studies identified the mammalian solu-
ble ATPase, Asna1/TRC40, as part of a cytosolic complex that in-
teracts with the newly synthesized TA protein, Sec61b, in vitro
(Stefanovic and Hegde, 2007; Favaloro et al., 2008). This complex
can then deliver Sec61b to the surface of ER-derived vesicles (mi-
crosomes), where upon it can undergo ATP-dependent mem-
brane insertion. While these studies have provided critical molec-
ular insights into the ATP-dependent biogenesis of TA proteins,
they leave several important questions unaddressed. First, it is un-
clear how broad a role the Asna1/TRC40 system plays in vivo. In-
deed, a recent report established that the cytosolic chaperone
pair Hsc70/Hsp40 is sufficient to mediate efficient ATP-depen-
dent insertion of Sec61b in vitro (Abell et al., 2007). Second, the
identity of the proteins necessary for recruiting Asna1/TRC40 to
the ER is unknown. Finally, it is unknown how cells ensure proper
partitioning of TA proteins between the ER and mitochondria.
Based on a large-scale genetic interaction map of the secretory
pathway, we previously suggested that three otherwise unassoci-
ated yeast proteins (Mdm39/Get1, Rmd7/Get2, and Arr4/Get3,
the yeast homolog of Asna1/TRC40) cooperate tocarryout a com-
mon function that strongly impacts on trafficking and, accordingly,
named them Get1–3 (Golgi ER trafficking 1–3) (Schuldiner et al.,
2005). In agreement with this idea, we and others have found
that all three Get proteins physically associate (Auld et al., 2006;
Ho et al., 2002; Schuldiner et al., 2005), and that loss of any of
the GET genes leads to a pronounced Kar2 secretion phenotype,
suggestive of a defect in retrograde Golgi to ER trafficking
(Schuldiner et al., 2005). However, the full range of phenotypes
that have now been reported for the respective get deletions are
difficult to reconcile with an isolated defect in trafficking. These in-
clude mitochondrial dismorphogenesis (Dimmer et al., 2002) for
Dget1 (Dmdm39); defects in DNA replication or damage response
(Zewail et al., 2003) and V-type ATPase dysfunction (Sambade
et al., 2005) for Dget2 (Dhur2/Drmd7); sensitivity to toxic metal
ions (Shen et al., 2003) and effects on protein degradation machin-
ery (Auld et al., 2006) for Dget3 (Darr4); and defects in meiotic
spore formation (Auld et al., 2006; Enyenihi and Saunders, 2003)
for all deletions inGETgenes. Thus, the underlying molecular func-
tion(s) of the Get proteins, and the extent to which they are working
together to perform a single molecular role, remained unresolved.
Here we show, both in vivo and in vitro, that the GET complex
is the machinery responsible for insertion of secretory pathway
TA proteins into the ER membrane, and that the reduction in in-
serted TA proteins can, in turn, explain the wide array of pheno-
types observed for deletions in the GET genes.RESULTS
Get1 and Get2 Form a Membrane Receptor
for Get3 on the Face of the ER
We began our functional analysis of the GET complex by explor-
ing how Get1 and Get2 determine the subcellular localization of
Get3 (for analysis of the physical and functional relationship be-
tween the Get proteins see Figures S1 and S2 available online).
Earlier studies established that Get3, which, unlike Get1 and
Get2, is not predicted to have TMDs, is found on the surface of
the ER as well as in the cytosol. Moreover, in the absence of
Get1 and/or Get2, Get3 loses its ER localization, and is found
both in the cytosol as well as in poorly characterized punctate
structures (Auld et al., 2006; Schuldiner et al., 2005). Here we re-
veal that, rather than being membrane vesicles, these punctate
structures are in fact cytosolic detergent-insoluble aggregates
(Figure S3). We further show, through in vitro experiments with
microsomes and proteoliposomes containing Get1 and Get2,
that the Get1/Get2 complex is directly responsible for recruiting
Get3 to the ER membrane in an ATP-independent manner (Fig-
ure 1). This appears to be the primary role of Get1/2 complex,
as, in the absence of Get3, there is no apparent additional cost
to deleting Get1/2 (Auld et al., 2006; Schuldiner et al., 2005)
(Figure S4). The fact that Get3 shuttles between the cytosol
and the ER suggests that it may deliver substrates to the mem-
brane. In the context of this model, the formation of aggregates
and the exacerbated phenotype found in Dget1/Dget2 cells
(Auld et al., 2006; Schuldiner et al., 2005) (Figure S4) would be
explained by disruption of the Get3 cycle, leading to sequestra-
tion of potential substrates.
Get3 Binds the TA Protein Sed5 and Is Necessary
for Its Membrane Targeting
To help identify factors that might be shuttled from the cytosol to
the ER by the GET system, we performed a yeast two-hybrid
(Y2H) screen for polypeptides that can interact with Get3. Y2H
analysis, which reports on weak interactions occurring within
the nucleus of assayed strains, is well suited for identifying
Get3 binding proteins, as it can detect transient interactions
that are independent of the presence of Get1 and Get2. We
used yeast expressing Get3 as bait to screen a genomic library
encoding prey proteins (James et al., 1996). Physical interac-
tions caused activation of the Gal4-driven HIS3 reporter gene, al-
lowing growth on plates lacking histidine. The strongest hit from
the screen was a fragment of Sed5 (amino acid 197 to the C ter-
minus) (Figure 2A), a TA protein that acts as a SNARE in vesicular
traffic within the Golgi and between the Golgi and the ER (Hard-
wick and Pelham, 1992). The Get3-Sed5 interaction was depen-
dent on the presence of the C-terminal TMD (Figure 2A).
We next examined whether Get3, as part of the GET complex,
plays a role in recruiting newly synthesized Sed5 in the cytosol
and inserting it into membranes. We visualized the subcellular
localization of Sed5 with an N-terminal fusion protein with GFP
(GFP-Sed5) (Weinberger et al., 2005). N-terminal GFP fusion
was compatible with the correct targeting of Sed5 to the Golgi
in control cells (Banfield et al., 1994; Weinberger et al., 2005)
(Figure 2B). Deletion of Get3 led to a large pool of soluble protein
and a corresponding decrease in Golgi-like puncta containingCell 134, 634–645, August 22, 2008 ª2008 Elsevier Inc. 635
Figure 1. Get1 and Get2 Act as a Membrane Receptor for the Soluble Get3
(A) Western blots with aGet3 showing binding of recombinant Get3 ATPase to microsomes prepared from Dget3 or Dget1/2/3 strains in the presence or absence
of ATP. Shown are Optiprep gradient fractions, which separate microsomes from unbound protein.
(B) Western blots with aGet3 or aPhs1 showing binding of recombinant Get3 to proteoliposomes reconstituted with either Phs1 as a control protein (Get1/
Get2+PHS1) or purified Get1-PC and Get2-HA (+Get1/+Get2). Shown are optiprep gradient fractions as above.Sed5 (Figure 2B). In a Dget1/Dget2 background, this defect was
more pronounced; there was only modest Golgi staining and, in-
stead, we observed cytosolic fluorescence and a few large
punctate structures that were distinct from the Golgi, as visual-
ized by Anp1-GFP staining (Figure 2B). Red fluorescent protein
(RFP) fused to Get3 (Get3-tdRFP) and GFP-Sed5 colocalized
in these punctate structures (Figure 2C). Thus, in the absence
of the Get proteins, a substantial fraction of Sed5 remains in
the cytosol. Consistent with this, subcellular fractionation exper-
iments indicate that deletion of the GET genes leads to reduced
levels of endogenous untagged Sed5 in membranes, while not
interfering with membrane association of the Golgi protein
Emp47 or the ER protein Sec61 (Figure 2D).
Decreased Sed5 SNARE activity in vesicles traveling between
the Golgi and ER could slow down retrograde traffic and reduce
the efficiency of cellular retrieval mechanisms of ER resident pro-
teins (Hardwick and Pelham, 1992; Yamaguchi et al., 2002). We
therefore tested whether reduced Sed5 function could explain
the Kar2 secretion phenotype observed in the get mutants. Con-
sistent with this hypothesis, lowering protein levels of the essen-
tial Sed5 protein, by using a repressible tetO7 promoter (Mnaim-
neh et al., 2004), caused Kar2 secretion at levels that were similar
to those observed in deletions of GET complex members
(Figure 2E). Moreover, overexpression of Sed5, presumably by
allowing sufficient Sed5 to insert into membranes by alternate,
potentially spontaneous TA-insertion pathways (see Discus-
sion), suppressed the Kar2 secretion defect in a triple-deletion
strain that has no GET complex members (Figure 2F). We there-
fore conclude that the GET complex plays a major role in the bio-
genesis of the TA protein Sed5. In addition, the Kar2 secretion
phenotype of these cells could be explained by the reduced
levels of Sed5 in the membranes of get deletion mutants.
The GET Complex Plays a Broad Role in Insertion
of TA Proteins into Membranes
The role of the GET complex as a specific chaperone system for
the TA protein Sed5 cannot explain the diversity of the pheno-636 Cell 134, 634–645, August 22, 2008 ª2008 Elsevier Inc.types displayed by deletions of GET genes. The recent finding
that the mammalian Get3 homolog Asna1 was involved in the
insertion of in vitro synthesized Sec61b (Stefanovic and Hegde,
2007; Favaloro et al., 2008) suggests that the GET complex
has a broader role in TA protein biogenesis. Consistent with
this idea, by a directed Y2H approach, we detected physical in-
teractions between Get3 and several additional secretory path-
way TA proteins, including the SNAREs Tlg2 and Sec22 and
the peroxisomal TA protein Pex15. These interactions, as
observed for Sed5, were dependent on the presence of the
C-terminal TMD (Figure 3A). Although these data suggest that
Get3 can specifically recognize a range of C-terminally located
TMDs, it appears to have some selectivity, as we could not de-
tect physical interactions for the mitochondrial TA protein Fis1
(Figure 3A), which, like other mitochondrial TA proteins, has
a shorter, more hydrophilic TMD than secretory pathway TA pro-
teins (Beilharz et al., 2003; Borgese et al., 2001, 2007).
To test whether the observed physical interactions reflect an
in vivo role for the GET complex in the biogenesis of secretory
pathway TA proteins, we looked at the effect of loss of the
Get1/Get2 receptor on the subcellular localization of a function-
ally diverse range of TA proteins. We focused predominantly on
ER-localized TA proteins, as interpretation of effects on their lo-
calization is not complicated by trafficking defects seen in get
mutant strains. Accordingly, we expressed N-terminal fluores-
cent protein fusions to Sbh1, Sbh2—the yeast homolog of
Sec61b shown to interact with Asna1 (Stefanovic and Hegde,
2007)—Scs2, and Ysy6. As observed for Sed5, localization of
these TA proteins was normal in control cells, but was altered
in a Dget1/Dget2 background (Figure 3B). During logarithmic
growth, we could observe both the presence of large puncta
(that colocalize with Get3) and also proper ER localization,
(Figure S5). Following the diauxic shift, which occurs as cells
exit log phase, we observed a more pronounced defect. In
most cells, the majority of the protein was either cytosolic or in
one or two large puncta that also contained Get3 (Figure S6).
These defects are specific for TA proteins entering the secretory
Figure 2. Get3 Binds to Sed5 and Is Important for Its Biogenesis In Vivo
(A) Yeast two-hybrid assay with Get3 as bait and Sed5197–340 (the strongest hit from the Y2H screen) as prey (in the presence or absence of its TMD). The growth
on medium lacking histidine (HIS) is indicative of a physical interaction.
(B) Fluorescence microscopy demonstrating a shift in the subcellular localization of GFP-Sed5 from Golgi in control (WT) strains to a partially cytosolic localization
in a Dget3 strain, and both cytosolic and few large puncta in Dget1/2 strains. The GFP-Sed5 puncta in get mutants do not colocalize with the Golgi marker
Anp1-RFP.
(C) Fluorescence microscopy demonstrating colocalization of GFP-Sed5 and Get3-tdRFP in cytosolic aggregates that form in a Dget1/2 background.
(D) Western blots of cell fractionation experiments to determine levels of Sed5 in membrane fractions. Control (WT), Dget1/2 or Dget3 strains were divided into
three fractions (Heavy Mem, Lighter Mem, and remainder of cellular proteins [Other]) and compared to input protein (Input) with Western blots immunostained
against either Sed5 or the control Golgi transmembrane protein, Emp47, and ER transmembrane protein Sec61.
(E) Western blots of secreted proteins with aKar2. Assay for Kar2 secretion was performed on a control strain (WT), mutants of the GET complex (Dget1, Dget2,
Dget3), and on a yeast strain harboring a repressible allele of the essential TA protein Sed5 (tet-SED5), either in the presence (+Dox) or absence (Dox) of the
corepressor doxycycline.
(F) Western blots of secreted proteins with aKar2. Assay for Kar2 secretion was performed on the triple mutant (Dget1/2/3) either alone or overexpressing SED5
from a high copy plasmid (+ OE SED5), and compared to a control strain (WT).pathway, as the two mitochondrial TA proteins examined (Fis1
and Tom22) properly localized in both the control and a Dget1/
Dget2 background (Figure 3C).
Loss of the GET Complex Leads to Mislocalization
of a Subset of TA Proteins
The finding that Get3 is able to distinguish between TA proteins
destined for the secretory pathway and those destined to mito-
chondria suggests that, in addition to increasing the efficiency
of TA protein membrane insertion, the GET complex helpsensure that TA proteins accurately find their destination mem-
brane. Consistent with this idea, we observed that, when overex-
pressed, a subset of secretory pathway TA proteins mislocalize
to mitochondria in Dget1/Dget2 strains (an example of the TA
protein Ubc6 is given in Figure 4A). This effect was particularly
pronounced for Pex15. In wild-type (WT) cells, this protein is
thought to be first inserted into the ER, and then transported to
the peroxisome via Pex19 (Elgersma et al., 1997; Hoepfner
et al., 2005; Tam et al., 2005) (supported by data in Figure S7).
However, in Dget1/Dget2 cells, Pex15 initially formed cytosolicCell 134, 634–645, August 22, 2008 ª2008 Elsevier Inc. 637
Figure 3. The GET Complex Affects the Biogenesis of aWide Variety
of TA Proteins
(A) Y2H assay showing Get3 as bait and various TA proteins (in the presence or
absence of their TMDs) as prey. The growth on medium lacking histidine
(HIS) is indicative of a physical interaction.
(B) Fluorescence microscopy of control (WT) and Dget1/2 strains expressing
a broad variety of TA proteins. GFP-Scs2, GFP-Sbh1, and GFP-Ysy6 under
a galactose-inducible (GAL) promoter. Cherry-Sbh2 was expressed from a
plasmid under the constitutive TEF2 promoter.
(C) Fluorescence microscopy of control (WT) and Dget1/2 strains expressing
two mitochondrial TA proteins, Cherry-Fis1 and Cherry-Tom22, expressed
from a plasmid under the constitutive TEF2 promoter.638 Cell 134, 634–645, August 22, 2008 ª2008 Elsevier Inc.aggregates (Figure S8), but, after extended overexpression, be-
gan to appear in mitochondrial membranes (Figure 4B). This sug-
gests that, once Pex15 saturated Get3, it could insert inappropri-
ately into mitochondrial membranes. Indeed, we observed that,
in the absence of Get3, this lag phase is shortened dramatically,
and Pex15 is found in the mitochondria at much earlier time
points (Figure 4B). Hence, in addition to increasing the efficiency
of insertion of TA proteins, recognition by Get3 represents a key
decision step in defining the membrane destination of a TA pro-
tein, thus overcoming the intrinsic potential for TA proteins to
spontaneously insert into a wide range of membranes.
Loss of TA Proteins Recapitulates the Pleiotropic
GET Phenotypes
The diversity of TA protein functions suggests that the pleiotropic
effects associated with loss of the GET complex might be a sec-
ondary consequence of TA protein mislocalization. To test this
idea, we assembled a library of strains carrying mutant alleles
for each of the predicted 55 yeast TA proteins (Beilharz et al.,
2003) (including the six TA proteins localized to mitochondria),
and plated these strains on various conditions for which we ob-
served sensitivity in the get deletion strains. The library consisted
of 43 deletion strains (Giaever et al., 2002) for nonessential TA
proteins and 12 hypomorphic alleles of the essential ones. Hypo-
morphic alleles were made by using the decreased abundance
by mRNA perturbation (DAmP) method (Schuldiner et al.,
2005), which typically results in 5- to 10-fold decrease in levels
of the endogenous protein.
We found that loss of a large number of TA proteins (Dpep12,
Dtlg2, Dsec22, Dvam3, Dscs2, Dsso2, Dgos1, and bos1-DAmP)
caused pronounced copper sensitivity (see Figure 5 for the most
sensitive strains). This is consistent with an important role of the
late secretory pathway in cellular copper homeostasis (Labbe
and Thiele, 1999). More generally, individual TA protein mutant
strains were sensitive to only a subset of the conditions. How-
ever, for every condition tested, we found a subset of TA protein
deletions/depletions that fully recapitulate the sensitivities found
in the Dget1 and Dget2 strain (Figure 5 shows the strains with
strongest sensitivities). Thus, a broad defect in secretory
pathway TA protein insertion could fully account for the diverse
phenotypes observed upon loss of the Get1/Get2 receptor.
In Vitro Evidence that the GET Complex Directly
Mediates Insertion of Newly Synthesized
TA Proteins into the ER membrane
The above studies establish that the Get proteins play a critical
role in the biosynthesis and proper localization of a wide range
of TA proteins. Given the pleiotropy of phenotypes displayed
by the get deletants, we wished to assess whether the Get pro-
teins are directly required for insertion of TA proteins into the ER
membrane. We therefore developed an in vitro system for study-
ing this process, which takes advantage of our ability to prepare
cytosol extracts and microsomes from get mutant yeast strains.
To monitor membrane insertion, we engineered a glycosylation
site after the TA sequence of each substrate examined. Follow-
ing translocation, this site is expected to gain access to the
glycosylation machinery in the lumen of the ER (Borgese et al.
[2001] and Figure S9) and, as such, serve as a proxy for
Figure 4. Role of GET Proteins in Creating Membrane Specificity
(A) Fluorescence microscopy showing the localization of GFP-Ubc6 and mitochondrially targeted dsRED (MTS-RFP) in a control (WT) or Dget1/2 strain.
(B) Fluorescence microscopy of a time course monitoring the subcellular localizations of the peroxisomal TA protein GFP-Pex15 as well as dsRED targeted to the
mitochondria (MTS-RFP) following induction of Pex15 from a galactose inducible promoter in a control (WT), get1/2, or get3 strain.translocation. Indeed, when we combined cytosol and micro-
somes from WT cells, we observed efficient translocation of pre-
proalpha factor (a canonical Sec61 substrate) (Figure 6A) and of
the three secretory pathway TA proteins that we tested: Sed5
(Figure 6B), Sec22 (Figures 6C and 6D), and Ysy6 (Figure S9).
In contrast, we did not detect any translocation of the mitochon-
drial TA protein Fis1 (Figure 6B), indicating that our in vitro sys-
tem faithfully recapitulates the target membrane specificity of
TA protein insertion.
To evaluate the role of the Get proteins in TA protein insertion,
we prepared extracts from a Dget3 strain and microsomes from
a Dget1/2 strain. Strikingly, these mutant extracts and micro-
somes were defective for insertion of TA proteins (Figures 6B–
6D and S9), while being fully proficient in supporting the translo-
cation of preproalpha factor (Figure 6A and data not shown).
Addition of recombinant Get3 to Dget3 extracts during
(Figure 6C), but not after (data not shown), translation allowed
for robust insertion, thus demonstrating that this defect is a prox-
imal consequence of not having Get3 in the in vitro system, and
not due to altered cellular physiology in Dget3 strains. Get3 also
appears to be limiting in our WT extracts, as we saw enhanced
translocation when recombinant Get3 was added (Figures 6C
and S9). Critically, this Get3-mediated insertion is completely
dependent on the presence of the Get1/2 complex in the micro-somes (Figures 6D and S9), providing further evidence that these
three proteins cooperate to carry out insertion of TA proteins.
Taken together, these data establish that the GET system is di-
rectly responsible for mediating insertion of newly synthesized
TA proteins into the ER membrane.
DISCUSSION
The present study defines a pathway by which cells ensure the
efficient and accurate biogenesis of TA proteins destined for
the secretory pathway. The soluble cytosolic ATPase, Get3, spe-
cifically queries newly synthesized proteins for the presence of
C-terminally localized hydrophobic domains. Get1 and Get2
then serve as an ER membrane receptor, which recruits the
Get3-TA complex, thereby promoting the proper insertion of
TA proteins into the ER (Figure 7A). Once inserted, TA proteins
can then be routed to their ultimate destination within the secre-
tory pathway. In the absence of the heteromeric Get1/Get2 re-
ceptor, TA proteins bound to Get3 fail to reach ER membranes,
and are instead trapped in large cytosolic aggregates
(Figure 7B). This leads to a broad depletion of TA proteins, which
in turn can account for the otherwise confusing array of pheno-
types associated with loss of Get proteins. Binding to Get3 is
also a decisive step in the insertion pathway, as in its absence,Cell 134, 634–645, August 22, 2008 ª2008 Elsevier Inc. 639
secretory pathway TA proteins may insert into mitochondrial
membranes (Figure 7C).
The finding that the GET pathway is not essential for yeast vi-
ability provides in vivo support to in vitro studies that had sug-
gested additional mechanisms by which TA proteins can find
their destination membranes (Rabu and High, 2007). Nonethe-
less, several considerations suggest that the GET pathway is
the major route used to target a broad range of TA proteins to
the secretory pathway. First, our Y2H analysis indicates that
Get3 can bind multiple secretory pathway TA proteins in
Figure 5. Reduced Levels of TA Proteins Can Explain the Diverse
Array of GET Complex Phenotypes
Serial dilutions in different conditions: SD + CuSO4 (Cu), SD + hydroxyurea
(HU), SD + tunicamycin (Tunic.), SD + hygromycin (Hygro.), and YPD incubated
at 39C (39C). Strains shown are: control cells (WT), get mutants, five TA pro-
tein deletion strains, and a strain carrying a hypomorphic allele (DAmP) of an
essential TA protein. Copper sensitivity in theDget3 strain is more pronounced
in methionine prototrophic than auxotrophic cells. We used Dmet15 cells for
this panel, resulting in a less sensitive phenotype compared with MET+ cells
depicted in Figure S4.640 Cell 134, 634–645, August 22, 2008 ª2008 Elsevier Inc.a TMD-dependent manner. Second, for all secretory pathway
TA proteins examined, the interaction with Get3 caused seques-
tration of the TA proteins into cellular aggregates in the absence
of Get1 and Get2. This suggests that, when Get3 is present, most
of the natural flux of TA proteins flows through the GET pathway.
Indeed, yeast fail to grow when Get3 is overexpressed in the ab-
sence of Get1 and Get2 (Figure S4). Third, deletion of Get3,
which would eliminate the GET pathway without actively pre-
venting TA proteins from utilizing alternate pathways by trapping
them in nonproductive Get3 complexes, still leads to diverse cel-
lular defects. Finally, in vitro reconstitution experiments directly
establish that Get3 cooperates with the Get1/2 complex in medi-
ating the insertion of newly synthesized TA proteins. Thus the
ability of cells to survive in the complete absence of the Get pro-
teins may be analogous to the viability of yeast missing the SRP,
which is made possible by the existence of alternate pathways
for insertion of the numerous secreted and membrane-bound
proteins that normally utilize this machinery (Ogg et al., 1992).
Possible alternate routes for TA protein biogenesis that have
been suggested by in vitro studies include spontaneous inser-
tion, which occurs efficiently for some TA proteins, such as
CytB5 (Brambillasca et al., 2006). In addition, purified Hsc70/
Hsp40 can promote the ATP-dependent (Abell et al., 2007) and
SRP the GTP-dependent insertion of other TA proteins, such
as Sec61b, (Abell et al., 2004). Such back-up systems, however,
would lack the strong membrane specificity conferred by the ER
localization of the Get1/2 complex, as well as the preferential
binding of Get3 to TA proteins destined to the secretory path-
way. The potential importance of such specificity is illustrated
by the observation that some TA proteins, including Pex15 and
Ubc6, mislocalize to the mitochondria when the GET system is
impaired. This argues that, shortly after synthesis, Get3 com-
petes with other factors (possibly Hsc70 and/or components
that play an analogous role to Get3 in the targeting of mitochon-
drial TA proteins) for TMD binding, and that Get3 recognition
commits the TA proteins to their subsequent insertion into ER
membrane. It remains to be determined whether a dedicated
protein machinery exists that ensures the accurate targeting of
mitochondrial TA proteins, or whether the shorter, more hydro-
philic nature of their TMDs prevents Get3 binding, thereby allow-
ing for efficient, spontaneous insertion into the mitochondria.
The interaction between Get3 and a TA protein substrate may
thus represent a critical and potentially regulated decision step
for establishing the destination target of TA proteins. Regulation
could globally alter Get3 function or specifically affect the inter-
action between Get3 and target TA proteins. Along these lines,
we have recently found that the function of Get3 is modulated
by its redox state (our unpublished data and Metz et al. [2006]).
In addition, Get3 is transcriptionally upregulated under both
cytosolic (Auld et al., 2006) and ER (Travers et al., 2000) stress
conditions. It has also been found that many TA proteins are pal-
mitoylated (Roth et al., 2006) or phosphorylated (such as for
Sed5 [Weinberger et al., 2005]) on residues that are immediately
adjacent to the TMD. Such modifications could modulate Get3
recognition by creating negatively charged flanking regions or
by altering the hydrophobicity of the TMD, thereby enabling
the coordinated regulation of subclasses of TA proteins and
altering the physiology of the cell.
Figure 6. In Vitro Reconstitution of GET-Dependent Insertion of TA Proteins
(A) Autoradiograph of in vitro-translated, 35S methionine-labeled, a-factor (afac) following incubation in the presence of microsomes derived from WT or Dget1/2
strains. The position of untranslocated prepro-afac and glycosylated, translocated pro-afac (gafac) are indicated.
(B) Autoradiograph of in vitro translated, 35S methionine-labeled Sed5 and Fis1 following incubation with microsomes derived from WT orDget1/2 strains. Prior to
SDS-PAGE analysis, samples were immunoprecipitated with an anti-opsin antibody and then treated with EndoH, as indicated. The position of untranslocated
Sed5 and Fis1 as well as glycosylated translocated Sed5 (gSed5) are indicated.
(C) Graph representing the dose dependence of Sec22 translocation on addition of recombinant Get3 to either WT- or Dget3-derived translation extracts. WT
microsomes were added following translation, and the amount of glycosylated Sec22 relative to total Sec22 was calculated. Results from three independent
experiments are shown; data are presented as mean ± SD.
(D) Autoradiograph of in vitro-translated, 35S methionine labeled, Sec22 following translation in WT cytosol supplemented with optimal levels of Get3. Translo-
cation was terminated at the indicated times following addition of microsomes derived from either WT orDget1/2 strains. The position of untranslocated Sec22 as
well as glycosylated translocated Sec22 (gSec22) are indicated.While the present studies focused on TA biogenesis in yeast,
recent observations suggest that the GET pathway plays an es-
sential role in TA biogenesis in higher eukaryotes. Biochemical
studies revealed that the mammalian Get3 homolog, Asna1/
TRC40, binds the TA protein, Sec61b, and facilitates its post-
translational insertion into ER membranes (Stefanovic and
Hegde, 2007; Favaloro et al., 2008). An in vivo role of Asna1 in
TA biosynthesis in metazoans is suggested by the impaired ca-
pacity for insulin secretion in Caenorhabditis elegans mutants of
asna1 (Kao et al., 2007). In light of our findings, an attractive hy-
pothesis is that impaired insulin secretion results from compro-
mised biogenesis of one or more of the SNARE TA proteins.
The broader importance of the GET pathway is underscored
by the finding that complete loss of ASNA1 causes early embry-
onic lethality in mice (Mukhopadhyay et al., 2006) and arrested
growth at the L1 stage in C. elegans (Kao et al., 2007). The mo-
lecular identity of the Get3 ER receptor in metazoans remains
to be established. However, we find that Ysy6 translated in rabbit
reticulocyte extracts inserts into yeast microsomes in a Get1/2-dependent manner, suggesting that the GET pathway is highly
conserved (data not shown). Consistent with this, PSI-BLAST
analysis identifies the WRB protein as an excellent and ubiqui-
tously expressed candidate for a Get1 ortholog.
In summary, the GET complex in yeast and likely metazoans
constitutes the major machinery necessary for membrane selec-
tive, and ATP-dependent insertion of TA proteins. This finding
should now enable mechanistic studies to explore central
questions, including how the GET system selects substrate
and exploits ATP hydrolysis to overcome the energetic barriers
to insertion of transmembrane proteins into lipid bilayers.
EXPERIMENTAL PROCEDURES
Strains and Media
Due to a high rate of reversion, all deletions in GET genes were constructed by
sporulating from a heterozygous diploid carrying deletions in all three genes
(his3D1/his3D1 leu2D0/leu2D0 LYS2/LYS2 MET15/met15D0 ura3D0/ura3D0
can1D::STE2pr-spHIS5/CAN1 lyp1D::STE3pr-LEU2/LYP1 cyh2/CYH2 GET1/
Dget1::cgURA3 GET2/Dget2::NATr GET3/D::Kanr). Following sporulation,Cell 134, 634–645, August 22, 2008 ª2008 Elsevier Inc. 641
single-, double-, and triple-deletion strains of the correct genotype were cho-
sen. For Figure 5, all strains were chosen to beDmet15 to be isogenic with de-
letion strains taken from the Yeast Consortium Deletion Library (Giaever et al.,
2002) or made by the DAmP method (Schuldiner et al., 2005). Deletion con-
structs used were pFA6-NAT and pFA6-Kan (Longtine et al., 1998) or pCG-
URA (Kitada et al., 1995). Galactose (GAL) inducible strains were made on
the same background as the deletions, only pFA6-Kanr-GALp or pFA6-
Kanr-pGAL-GFP cassette was used (Longtine et al., 1998). C-terminally
tagged Get3-GFP::His, Anp1-RFP::Kanr, and Pex3-RFP::Kanr were taken
from the whole genome GFP tag library (Huh et al., 2003). The tetO7-SED5
strain was picked from the essential gene promoter shut-off collection (Mnaim-
neh et al., 2004). All N-terminal-tagged proteins with mCherry were created
with a pFA6-based vector (Kind gift from David Breslow, University of Califor-
nia, San Francisco), carrying a URA3-TEF2 promoter-mCherry, and were inte-
grated into the gene by one-step PCR-based homologous recombination, with
appropriate primers that also introduced an N-terminal linker (GDGAGL) be-
tween the mCherry and the proteins. pRS315-GFPSed5 was a kind gift of
Anne Spang (Weinberger et al., 2005). p416MET25-Get3-tdRFP was con-
structed by fusing the tdRFP (Campbell et al., 2002) open reading frame to
the 30 end of the GET3 open reading frame via an engineered NotI site coding
for three alanines. For colocalization purposes, a mitochondrial targeting se-
quence containing RFP was used as a mitochondrial marker (kind gift of
Figure 7. Schematic Model for GET Complex Function
(Top) WT cells. Get3 recognizes newly synthesized, ER-destined
TA proteins. The Get3-TA complexes dock onto the Get1/Get2
receptor. This allows insertion of TA proteins.
(Middle) Cells lacking the receptor (Dget1/2). Get3-TA complexes
fail to reach the ER and, instead, are sequestered in cytosolic
aggregates.
(Bottom) Cells lacking Get3 (Dget3). Newly synthesized TA pro-
teins intended for the ER are no longer shuttled into the GET path-
way. To varying degrees, depending on the TA proteins, they may
use alternate ATP/GTP-dependant pathways or spontaneous
routes for membrane insertion. This could lead to misinsertion
into the mitochondria, inefficient insertion into the ER, or aggrega-
tion in the cytosol.
Jodi Nunnari, University of California, Davis). For the strong over-
expression plasmid employed in Figure 1H, SED5 was cloned into
the 2 mm plasmid BFGIII under the control of its own promoter.
Plates used for drug sensitivity assays were: SD + 100 mM
HU (Sigma), SD + 1mg/ml tunicamycin (Sigma), SD + 100 mg/ml
hygromycin (Sigma), and SD + 1mM CuSO4. YPD plates were
used for heat sensitivity assays at 39C. For induction of the
GAL, promoter cells were grown in YP + 2%Galactose.
Microsome Binding Experiments
Microsomes were isolated fromDget1/2/3 andDget3 yeast strains
as previously described (Wuestehube and Schekman, 1992), then
resuspended in reaction buffer (20 mM HEPES/KOH, pH 6.8,
5 mM MgAc2, 150 mM KAc, 250 mM sorbitol).
A volume of 10 ml of microsomes were mixed with 1 ml of 2 mM
Get3 purified from Escherichia coli (Metz et al., 2006), 0.5 ml 100
mM glutathione (Sigma), 1.25 ml 100 mM batho cuproine disulfonic
acid (BCS; SERVA), 1 ml 100 mM ATP (Sigma), and 14 ml of 23
ATPase buffer (200 mM HEPES/KOH, 20 mM MgCl2, 40% glyc-
erol, pH 7.0), and were incubated at 30C for 1 hr. After incubation,
samples were immediately mixed with 490 ml of 50% Optiprep
(PROGEN Biotechnik GmbH) solution in the reaction buffer, placed
in 2 ml ultracentrifugation tubes, and overlayed with 1160 ml
40% Optiprep solution in reaction buffer, and, finally, with 450 ml
of the reaction buffer. Samples were centrifuged at 166,000 3 g
for 3 hr at 4C. After centrifugation, four fractions were collected:
(1) 630 ml; (2) 430 ml; (3) 430 ml; (4) 640 ml. All fractions were precip-
itated with 50% TCA. Pellets were washed twice with 500 ml cold acetone and
dried at 37C for 1–5 min. Final pellets were resuspended in 13 SDS-PAGE
sample buffer.
Purification of GET Components
Get3 was purified as previously described (Metz et al., 2006). Epitope-tagged
versions of Get1 and Get2 were copurified from yeast (see Experimental Pro-
cedures in the Supplemental Data).
Liposome Binding Experiments
Proteoliposomes were prepared as described previously (Denic and Weiss-
man, 2007) and incubated with recombinant Get3. as described above in
Microsome Binding Experiments.
Y2H System
The Y2H system was performed as previously described (Metz et al., 2006).
For more details see Experimental Procedures in the Supplemental Data.
Fluorescence Microscopy
For Figure 2C, microscopy was performed with a Leica DM IRE2 microscope
(Leica Microsystems, Wetzlar, Germany). For Figure 2B, a DeltaVison restora-
tion microscope was employed. Raw images were deconvolved with the642 Cell 134, 634–645, August 22, 2008 ª2008 Elsevier Inc.
Cell 134, 634–645, August 22, 2008 ª2008 Elsevier Inc. 643additive algorithm of Softworx software. For live cell imaging, yeast were incu-
bated in synthetic complete medium at room temperature. Fixed yeast cells
were mounted in ProLong Gold antifade reagent with DAPI (Invitrogen). For
Figures 3 and 4, microscopy was performed in the UCSF Nikon Imaging Center
with a Yokogawa CSU-22 spinning disc confocal on a Nikon TE2000 micro-
scope. For more detailed information see Experimental Procedures in the
Supplemental Data.
Crude Fractionation
OD600 units of 25–50 were harvested from log-phase cells growing in YPAD
medium, washed once in water, and resuspended in 1 ml buffer (20 mM
HEPES/KOH, pH 7.3, 100 mM KCl, 1 mM glutathione, complete protease in-
hibitors, phosphatase inhibitors [Roche], 1 mM EDTA, 1 mM EGTA, 3 mM
BCS, 1 mM PMSF). Cells were broken by bead beating with 800 ml glass beads
for 10 min. Homogenates were cleared at 2000 rpm in a microcentrifuge and
the supernatant (input) was subjected to two sequential centrifugation steps
(13,000 rpm in a microcentrifuge [Heavy membranes] and 40,000 rpm in
a TLA45 rotor in a tabletop ultracentrifuge [Light membranes]). Pellets from
both steps were resuspended in 250 ml (Heavy) or 50 ml (Light) of the same
buffer as above. Equal protein concentrations of the collected fractions and
the remaining supernatant (Other) were loaded, resolved by SDS-PAGE, trans-
ferred to a nitrocellulose membrane, and analyzed by immunoblotting with
antisera against Sed5, Sec61, or Emp47.
Kar2 Secretion Assays
Kar2 secretion assays were performed as previously described (Schuldiner
et al., 2005). For more details see Experimental Procedures in the Supplemen-
tal Data.
In Vitro Transcription
mRNAs were prepared with the mMessage mMachine kit (with cap analog,
either SP6- or T7-driven, as appropriate) from Ambion. Alpha factor mRNA
was transcribed from pDJ100 (Garcia et al., 1991). For other messages, tem-
plate DNA was derived from PCR products amplified with a 50 primer contain-
ing the T7 promoter/alpha factor 50 UTR/kozak sequence/start codon and
50 region of homology, and a 30 primer containing, in antiparallel order, the
30 region of homology preceding the stop codon/opsin tag/alpha factor
30 UTR/polyA tail. Primer sequences are available upon request from the cor-
responding authors.
In Vitro Translation and Translocation
Yeast translational extracts were prepared from cells grown to OD600 1–2 in
YPD. Cells were washed and resuspended in 1 ml of lysis buffer (100 mM
KOAc, 2 mM Mg(OAc)2, 2 mM DTT, 20 mM HEPES-KOH, pH 7.4, complete
protease inhibitors from Roche) for every 6 g of dry cell pellet. The cell slurry
was frozen in liquid nitrogen and lysed by bead beating. The thawed lysates
were spun in an SS34 rotor at 10,000 3 g for 10 min. The low-speed superna-
tant was then spun in a TLA110 rotor at 49,000 rpm for 30 min. The high-speed
supernatant was collected (avoiding the very top and bottom layers) and
passed over a 5 3 5 ml (attached in series) HiTrap desalting column (GE
Healthcare) equilibrated in lysis buffer with 14% glycerol. OD280 fractions >40
were collected, pooled, and stored as frozen aliquots at 80C.
Prior to use, extracts were treated with micrococcal nuclease (Amersham or
NEB) to remove any endogenous mRNAs, as described previously (Garcia
et al., 1991).
Translation reactions contained 9.5 ml of nuclease-treated extract, 2.5 ml of
63 mix (132 mM HEPES-KOH, pH 7.4, 720 mM KOAc, 9 mM Mg(OAc)2,
4.5 mM ATP, 0.6 mM GTP, 150 mM creatine phosphate [Roche], 0.24 mM of
each amino acid except methionine [Promega], 10.2 mM DTT, 0.5 ml of creatine
phosphokinase [10 mg/ml in 50% glycerol; Roche], 0.5 ml RNasin [Promega],
1 ml S35-labeled methionine [ARC; >1000 Ci/mmol]).
Unless indicated otherwise, reactions were programmed with 1 ml of mRNA
(0.1–1.0 mg) and incubated at room temperature for 1 hr. Further translation
was stopped by addition of cycloheximide (1 mM). Microsomes (0.06 OD280)
were then added and translocation allowed to proceed for an additional
30 min at room temperature. RNAs were digested with an RNase cocktail(Ambion). Finally, loading buffer was added and the translation products
were analyzed by SDS-PAGE followed by phosphorimager analysis.
Preperation of Translocation-Competent, ER-Derived Microsomes
Preperation of translocation-competent, ER-derived microsomes was
performed as previously described (Brodsky, 2005). For more details see
Experimental Procedures in the Supplemental Data.
Immunoprecipitation and EndoH for In Vitro Reconstitution
Experiments
Immunoprecipitation and EndoH for in vitro reconstitution experiments were
performed as previously described (Stefanovic and Hegde, 2007). For more
details see Experimental Procedures in the Supplemental Data.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and nine
figures and are available with this article online at http://www.cell.com/cgi/
content/full/134/4/634/DC1/.
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